Royal London Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244M | Sell |
|
|||||
|
2025
Q1 | $285M | Buy |
|
|||||
|
2024
Q4 | $232M | Sell |
|
|||||
|
2024
Q3 | $271M | Buy |
|
|||||
|
2024
Q2 | $233M | Sell |
|
|||||
|
2024
Q1 | $268M | Buy |
|
|||||
|
2023
Q4 | $213M | Buy |
|
|||||
|
2023
Q3 | $191M | Buy |
|
|||||
|
2023
Q2 | $160M | Buy |
|
|||||
|
2023
Q1 | $159M | Buy |
|
|||||
|
2022
Q4 | $150M | Buy |
|
|||||
|
2022
Q3 | $122M | Sell |
|
|||||
|
2022
Q2 | $147M | Sell |
|
|||||
|
2022
Q1 | $155M | Buy |
|
|||||
|
2021
Q4 | $120M | Sell |
|
|||||
|
2021
Q3 | $100M | Sell |
|
|||||
|
2021
Q2 | $107M | Sell |
|
|||||
|
2021
Q1 | $105M | Buy |
|
|||||
|
2020
Q4 | $102M | Buy |
|
|||||
|
2020
Q3 | $82.2M | Buy |
|
|||||
|
2020
Q2 | $89.5M | Buy |
|
|||||
|
2020
Q1 | $63.4M | Buy |
|
|||||
|
2019
Q4 | $73.6M | Buy |
|
|||||
|
2019
Q3 | $61.7M | Sell |
|
|||||
|
2019
Q2 | $59.7M | Sell |
|
|||||
|
2019
Q1 | $66.7M | Buy |
|
|||||
|
2018
Q4 | $72.9M | Buy |
|
|||||
|
2018
Q3 | $61.1M | Sell |
|
|||||
|
2018
Q2 | $62.8M | Buy |
|
|||||
|
2016
Q2 | $34M | Sell |
|
|||||
|
2016
Q1 | $400K | Buy |
|
|||||
|
2015
Q4 | $37M | Buy |
|
|||||
|
2015
Q3 | $33.3M | Buy |
|
|||||
|
2014
Q4 | $335K | Buy |
|
|||||
|
2014
Q3 | $22.9M | Buy |
|
|||||
|
2014
Q2 | $19.4M | Buy |
|
|||||
|
2014
Q1 | $19.2M | Sell |
|
|||||
|
2013
Q4 | $19.2M | Buy |
|
|||||
|
2013
Q3 | $17.9M | Buy |
|
|||||
|
2013
Q2 | $15.5M | Buy |
|